Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Lab-on-a-Chip and Microfluidics: Companies, Technologies and Commercialization "Track B"

Charles Daitch's Biography



Charles Daitch, CEO, Akonni Biosystems Inc.

Dr. Daitch has been serving as CEO and Founder of Akonni Biosystems since 2003. He has 28 years experience encompassing a broad range of disciplines including chemistry, biology, biosensors and chemical/biological defense. He directs multidisciplinary teams of scientists and engineers focused on the development of integrated, next-generation diagnostic and biosensor systems. Several products developed under Dr. Daitch’s leadership have been designed for low resource, rugged settings.

Charles has 8 years of R&D experience gained from positions with the NIH/FDA, the USDA, and Sandia National Labs, followed by 20 years of commercial senior management experience (P&L responsibility) gained from positions at PSR, Veridian, HandyLab, CUBRC, and Akonni Biosystems corporations. He has 6 U.S. patents, 24 peer reviewed publications and serves on NIH and NSF review panels. Charles has served as principle investigator on over $40 million in commercial and government grants/ contracts and has successfully led equity financing rounds for Akonni totaling $43 million.

Charles Daitch Image

Perspectives on Developing a POC Diagnostic for Global Health

Tuesday, 2 October 2018 at 17:45

Add to Calendar ▼2018-10-02 17:45:002018-10-02 18:45:00Europe/LondonPerspectives on Developing a POC Diagnostic for Global HealthSELECTBIOenquiries@selectbiosciences.com

The aim of the panel is to discuss the challenges and opportunities in developing POC Dx for global health applications. This will be a panel discussion. Our panelists will share their perspectives on what it takes to succeed or fail developing POC diagnostics for global health applications as well as insights about funding global health POC diagnostics.


Add to Calendar ▼2018-10-01 00:00:002018-10-03 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics: Companies, Technologies and Commercialization "Track B"SELECTBIOenquiries@selectbiosciences.com